Author Archives: Alejandra Viviescas, PhD.

Hoth and Zylö Partner to Develop ‘Natural’ Cannabis-like Treatment for Lupus Skin Lesions

Hoth Therapeutics and Zylö Therapeutics entered into an agreement to jointly develop an endocannabinoid-based treatment for cutaneous lupus erythematosus (CLE), a lupus subtype that affects the skin. Endocannabinoids are cannabis-like molecules naturally produced by the human body, with similar effects to that of medical marijuana. The agreement gives Hoth an…